Literature DB >> 27533945

Melatonin has multiorgan effects.

Lionel H Opie1, Sandrine Lecour2.   

Abstract

Melatonin, widely used to counter transatlantic travel jet lag and insomnia, is synthesized in the suprachiasmatic nucleus of the anterior pituitary gland. Its release into the circulation is stimulated by the onset of darkness, followed by a progressive decrease in blood levels with the onset of dawn. Melatonin administration can maintain the quality of sleep and help to counteract age-induced cognitive decline. Melatonin can also limit the severity of a variety of cardiovascular and cerebrovascular diseases, diabetes, and cancer. Published on behalf of the European Society of Cardiology. All rights reserved.
© The Author 2015. For permissions please email: journals.permissions@oup.com.

Entities:  

Keywords:  Anticancer; Cardioprotection; Day–night cycle; Melatonin; Multiorgan; Sleep

Mesh:

Substances:

Year:  2016        PMID: 27533945     DOI: 10.1093/ehjcvp/pvv037

Source DB:  PubMed          Journal:  Eur Heart J Cardiovasc Pharmacother


  20 in total

1.  Connexin36 localization to pinealocytes in the pineal gland of mouse and rat.

Authors:  S G Wang; D D Tsao; K G Vanderpool; T Yasumura; J E Rash; J I Nagy
Journal:  Eur J Neurosci       Date:  2017-05-25       Impact factor: 3.386

Review 2.  Increasing Nrf2 Activity as a Treatment Approach in Neuropsychiatry.

Authors:  G Morris; A J Walker; K Walder; M Berk; W Marx; A F Carvalho; M Maes; B K Puri
Journal:  Mol Neurobiol       Date:  2021-01-07       Impact factor: 5.590

3.  Melatonin attenuates angiotensin II-induced abdominal aortic aneurysm through the down-regulation of matrix metalloproteinases.

Authors:  Jing Kong; Ya Zhang; Shanshan Liu; Hongxuan Li; Shangming Liu; Jingjing Wang; Xiaoteng Qin; Xiuxin Jiang; Jianmin Yang; Cheng Zhang; Wencheng Zhang
Journal:  Oncotarget       Date:  2017-02-28

4.  Suppression of Osteoclastogenesis by Melatonin: A Melatonin Receptor-Independent Action.

Authors:  Hyung Joon Kim; Ha Jin Kim; Moon-Kyoung Bae; Yong-Deok Kim
Journal:  Int J Mol Sci       Date:  2017-05-26       Impact factor: 5.923

Review 5.  Developmental Programming of Adult Disease: Reprogramming by Melatonin?

Authors:  You-Lin Tain; Li-Tung Huang; Chien-Ning Hsu
Journal:  Int J Mol Sci       Date:  2017-02-16       Impact factor: 5.923

6.  Melatonin and Hippo Pathway: Is There Existing Cross-Talk?

Authors:  Federica Lo Sardo; Paola Muti; Giovanni Blandino; Sabrina Strano
Journal:  Int J Mol Sci       Date:  2017-09-06       Impact factor: 5.923

Review 7.  Cardiovascular Benefits of Dietary Melatonin: A Myth or a Reality?

Authors:  Zukiswa Jiki; Sandrine Lecour; Frederic Nduhirabandi
Journal:  Front Physiol       Date:  2018-05-17       Impact factor: 4.566

8.  Effect of Melatonin on the Renin-Angiotensin-Aldosterone System in l-NAME-Induced Hypertension.

Authors:  Fedor Simko; Tomas Baka; Kristina Krajcirovicova; Kristina Repova; Silvia Aziriova; Stefan Zorad; Marko Poglitsch; Michaela Adamcova; Russel J Reiter; Ludovit Paulis
Journal:  Molecules       Date:  2018-01-29       Impact factor: 4.411

Review 9.  Melatonin in Heart Failure: A Promising Therapeutic Strategy?

Authors:  Frederic Nduhirabandi; Gerald J Maarman
Journal:  Molecules       Date:  2018-07-22       Impact factor: 4.411

10.  Physiological extremes of the human blood metabolome: A metabolomics analysis of highly glycolytic, oxidative, and anabolic athletes.

Authors:  Daniela Schranner; Martin Schönfelder; Werner Römisch-Margl; Johannes Scherr; Jürgen Schlegel; Otto Zelger; Annett Riermeier; Stephanie Kaps; Cornelia Prehn; Jerzy Adamski; Quirin Söhnlein; Fabian Stöcker; Florian Kreuzpointner; Martin Halle; Gabi Kastenmüller; Henning Wackerhage
Journal:  Physiol Rep       Date:  2021-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.